Several anti-smoking groups and doctors have filed a lawsuit challenging the U.S. Food and Drug Administration’s decision to delay its review of e-cigarettes.

The suit, filed Tuesday in a federal court in Maryland, accuses the agency of exceeding its authority and not following proper procedure last year when it pushed back to 2022 the deadline by which e-cigarette makers must submit their products for review. Plaintiffs in the suit argue that the delay harms public health, particularly for young people because it leaves them vulnerable to kid-friendly e-cigarettes and cigars that may lead to a lifetime of tobacco addiction.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]